The focus of my research will be guided by relevant clinical questions involved in the care of patients with glomerulonephritis. The thesis work on FSGS for my masters in epidemiology was inspired from my desire to use Toronto GN registry data to investigate our ability to predict relapses using clinical and biomarker data at the time of remission, and to predict ESKD using these same markers at the time of relapse. The data for the FSGS registry was also used to measure how duration of remission specifically impacts ESKD using novel statistical methods in glomerulonephritis research. My future research goals will be to continue assessing the impact of clinical, pathological, and genetic characteristics in FSGS disease with their association with outcomes, and broadly to investigate how novel biomarkers may be used for prediction models in glomerulonephritis. Collaborative discussion between the hereditary kidney disease clinics and onco-nephrology, combined with glomerular disease research is also an area of interest which may allow important clinical and research questions to be addressed for patients with nephrotic syndromes and immune complex glomerular diseases.